|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
ALL MATERIALS POSTED HERE EMBARGOED until 1700 GMT on 18 October 2011 For further information, contact: Preeti Singh
There will be a press briefing in Seattle, WA, USA on Tuesday, October 18th at 1400 GMT (7:00 a.m. Seattle / 10:00 a.m. NYC / 3:00 p.m. London / 4:00 p.m. Brussels / 5:00 p.m. Nairobi) For details and to RSVP, contact Preeti Singh (above), or see media advisory. Recording of Audio Press Briefing (mp3, 13.5 MB)
Communiqué de presse (en français) Fact sheet: RTS,S Malaria Vaccine Candidate Fact sheet: Phase III Trial of RTS,S Quotation from Professor Brian Greenwood, London School of Hygiene & Tropical Medicine
News organizations have permission for one-time use of images to accompany this story. Proper photo credit information must be included. |
|
|
||||
|
|
 |
|
